- metadata: - source: https://rwmalonemd.substack.com/p/bushwhacked-by-alex-berenson-on-fox - people: - [[Dr. Robert Malone]] - [[Alex Berenson]] - related: [[2022-01-16 Socrates, Thought Police, Ivermectin and Uttar Pradesh]] --- # Bushwhacked by Alex Berenson on Fox News > ## Excerpt > Professional jealousy is an ugly thing <iframe width="640" height="360" scrolling="no" frameborder="0" style="border: none;" src="https://www.bitchute.com/embed/DaNgNhGbe1UP/"></iframe> [Alex Berenson goes on Fox News and directly calls me a liar to my face and says I didn’t invent RNA vaccines](https://www.bitchute.com/video/DaNgNhGbe1UP/). --- Unprofessional, rude and an arsehole to boot. But beyond that, I think we can all assume CONTROLLED OPPOSITION. So, for Alex, who evidently doesn’t know how to do an internet search, find a patent and read it - I will make it easy for him. First - a couple of proof of principle experiments conducted in 1989 -from the patents with the priority date of 1989 (issued later, but the ideas/experiments date to March 21, 1989 as decided by the United States Patent Office) [](https://cdn.substack.com/image/fetch/f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fbucketeer-e05bbc84-baa3-437e-9518-adb32be77984.s3.amazonaws.com%2Fpublic%2Fimages%2F4d5a3708-eb6a-4617-95dd-3d8eb24ce69b_932x1122.png) [](https://cdn.substack.com/image/fetch/f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fbucketeer-e05bbc84-baa3-437e-9518-adb32be77984.s3.amazonaws.com%2Fpublic%2Fimages%2F7eb3ec50-da3d-48f1-8cc1-1f7c452db50f_942x1396.png) ## Early Patents priority dates from 1989 The first patents: - [Lipid-mediated polynucleotide administration to deliver a biologically active peptide and to induce a cellular immune response (includes mRNA).](https://patents.google.com/patent/US20030032615A1/en) [](https://pubchem.ncbi.nlm.nih.gov/patent/US-7250404-B2) P Felgner, JA Wolff, GH Rhodes, R Malone, D Carson. Assigned to Vical, Inc and licensed to Merck. No. 7,250,404, date of issue: 7/31/07 Cited in 105 articles. Priority Date: 3/21/1989. -  [Lipid-mediated polynucleotide administration to reduce likelihood of subject's becoming infected](https://patents.google.com/patent/US6867195B1/en) (includes mRNA). P Felgner, JA Wolff, GH Rhodes, Robert W Malone, D Carson. Assigned to Vical, Inc and licensed to Merck. US Pat. Ser. No. 6,867,195 B1. Date of issue: 3/15/05. Priority Date: 3/21/1989. - [Generation of an immune response to a pathogen (includes mRNA).](https://pubchem.ncbi.nlm.nih.gov/patent/US-6710035-B2) P Felgner, JA Wolff, GH Rhodes, Robert W Malone, D Carson. Assigned to Vical, Inc and licensed to Merck. US Pat. Ser. No. 6,710,035. Date of issue: 3/23/04. Citations: 39 articles. Priority Date: 3/21/1989. -  [Expression of exogenous polynucleotide sequences in a vertebrate, mammal, fish, bird or human (includes mRNA).](https://patents.google.com/patent/US6673776B1/en) P Felgner, JA Wolff, GH Rhodes, Robert W Malone, D Carson. Assigned to Vical, Inc, licensed to Merck.  US Pat. Ser. No. 6,673,776. Date of issue: 1/6/04. Priority Date: 3/21/1989. -  [Methods of delivering a physiologically active polypeptide to a mammal (includes mRNA).](https://app.dimensions.ai/details/patent/US-6413942-B1) P Felgner, JA Wolff, GH Rhodes, Robert W Malone, D Carson. Assigned to Vical, Inc, licensed to Merck. US Pat. Ser. No. 6,413,942. Date of issue: 7/2/02. (cited in 150 articles). Priority Date: 3/21/1989. -  [Induction of a protective immune response in a mammal by injecting a DNA sequence (includes mRNA).](https://patents.google.com/patent/US6214804B1/en) P Felgner, JA Wolff, GH Rhodes, Robert W Malone, D Carson. Assigned to Vical, licensed to Merck. US Pat. Ser. No. 6,214,804, date of issue: 4/10/01. Cited in 360 articles. Priority Date: 3/21/1989. - [Induction of a protective immune response in a mammal by injecting a DNA sequence (includes mRNA).](https://patents.google.com/patent/US5589466A/en) P Felgner, JA Wolff, GH Rhodes, Robert W Malone, D Carson. Assigned to Vical, Inc, licensed to Merck.  US Pat. Ser. No. 5,589,466. Date of issue: 12/31/96. Cited in 899 articles. Priority Date: 3/21/1989. - [Delivery of exogenous DNA sequences in a mammal (includes mRNA).](https://patents.google.com/patent/US5580859A/en) Assigned to Vical, Inc, licensed to Merck. P Felgner, JA Wolff, GH Rhodes, Robert W Malone, D Carson. US Pat. Ser. No. 5,580,859. Date of issue: 12/3/96. Cited in 1244 articles. Priority Date: 3/21/1989. - [Generation of antibodies through lipid mediated DNA delivery (includes mRNA).](https://patents.google.com/patent/US5703055A/en) P Felgner, JA Wolff, GH Rhodes, Robert W Malone, D Carson. Assigned to Vical, Inc, licensed to Merck. US Pat. Ser. No. 5,703,055. Date of issue: 12/30/97. Cited in 419 articles. Priority Date: 3/21/1989. Below are some of the descriptions of the invention taken from the above patents - priority date 1989. [](https://cdn.substack.com/image/fetch/f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fbucketeer-e05bbc84-baa3-437e-9518-adb32be77984.s3.amazonaws.com%2Fpublic%2Fimages%2F5782f879-72c5-43f1-9b86-8c554cec19d1_922x484.png) [](https://cdn.substack.com/image/fetch/f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fbucketeer-e05bbc84-baa3-437e-9518-adb32be77984.s3.amazonaws.com%2Fpublic%2Fimages%2F0510ed43-5b9f-426e-a678-397c24659115_930x590.png) Some of my papers and other patents on this subject area (1988-2000) - [A novel approach to study packaging of retroviral RNA by RNA transfection (Abstract).](https://www.rwmalonemd.com/s/J-A-Novel-Approach-to-Study-Packagnng-Ret-RNA-by-RNA-Tran-Malone-ColdSpringHarborpdf.pdf) RW Malone, P. Felgner, I. Verma. RNA Tumor Viruses, May 17-18, 1988. Cold Spring Harbor (the first in a series of papers/abstracts on RNA transfection). - [mRNA Transfection of cultured eukaryotic cells and embryos using cationic liposomes](https://www.rwmalonemd.com/s/KFocusmRNATransfectofCulturedEukCellembryos1989Data198820210212.pdf). Malone RW. Focus. 1989; 11:61-8 - [The SALK patent that was filed with the USPTO on 3/21/1989.](https://www.rwmalonemd.com/s/B-Cationic-Lipid-Mediated-RNA-and-DNA-patent-1988-Salk-Malon.pdf) Note that the cover letter hides this - and says it was filed on 3/29/89 - the sane date as all the VICAL patents, showing that there was collusion. WRITTEN BT ME IN 1988. - [THE VERY FIRST mRNA VACCINE EXPERIMENTAL DATA 1990 (from Vical to patent office)](https://www.rwmalonemd.com/s/First-mRNA-vaccination-data-March-21-1990.pdf) -  [Cationic liposome-mediated RNA transfection. Malone RW, Felgner PL, Verma IM. Proc Natl Acad Sci (PNAS) U S A. 1989;86(16):6077-81](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC297778/). Cited in 749 articles. -  [Direct gene transfer into mouse muscle in vivo. Wolff JA, Malone RW, et al. Science. 1990;247(4949 Pt 1):1465-8](https://science.sciencemag.org/content/247/4949/1465). Cited in 4,750 articles. Note that Robert was a student at Northwestern, and was never affiliated with University of Wisc. -  High levels of messenger RNA expression following cationic liposome mediated transfection tissue cultured cells. Malone R, Kumar R, Felgner P. NIH Conference: “Self-Cleaving RNA as an Anti-HIV Agent (abstract). Washington, DC June 1989. -  [Cationic liposome-mediated RNA transfection. Dwarki VJ, Malone RW, Verma IM. Methods Enzymol. 1993;217:644-54](https://pubmed.ncbi.nlm.nih.gov/7682647/). Cited in: 102 articles. -  Delivery of exogenous DNA (includes mRNA) sequences in a mammal P Felgner, JA Wolff, GH Rhodes, R Malone, D Carson. Biotechnology Advances 1993: 15 (3-4), 763-763 [For a deeper dive into the actual data, patent disclosures, meeting notes, lab books, etc, go to this webpage](https://rwmalonemdllc.com/mrna-vaccine-docs). Patents and papers - from the 1990s -  [DNA vaccines for eliciting a mucosal immune response (includes mRNA).](https://pubchem.ncbi.nlm.nih.gov/patent/US-6110898-A) US Pat. Ser. No. 6,110,898. Inventors: RW Malone and Jill Glasspool Malone. Date of issue: 8/29/00. Cited in 40 articles. Priority Date: 1996. - [Formulations and methods for generating active cytofectin: polynucleotide transfection complexes.](https://patents.google.com/patent/US5925623) Robert W Malone, et al. US Pat. Ser. No. 5,925,623 7/20/99. -  [Cationic Transport Reagents. US Pat. Ser. No. 5,892,071](https://patents.justia.com/patent/5892071) Robert W Malone, et. al. issued 4/06/99. -  [Polyfunctional cationic cytofectins, formulations and methods for generating active cytofectin: polynucleotide transfection complexes.](https://patents.google.com/patent/US5824812) Robert W Malone, et. al. US Pat. Ser. No. 5,824,812 issued 10/20/98. -  [Cationic Transport Reagents. Robert W Malone, et. al.](https://patents.google.com/patent/US5744625A/en) US Pat. Ser. No. 5,744,625 issued 4/28/98. -  [Cationic Transport Reagents. Robert W Malone, et. al.](https://patents.google.com/patent/US5527928A/en) US Pat. Ser. No. 5,527,928, date of issue: 6/18/96. -  [Marked enhancement of macaque respiratory tissue transfection by aurintricarboxylic acid.](https://www.liebertpub.com/doi/abs/10.1089/10430349950017707?journalCode=hum) Glasspool-Malone J, …, Malone RW. Gene Med. 2002;4(3):323-2. -  [Enhancing direct in vivo transfection with nuclease inhibitors and pulsed electrical fields.](https://pubmed.ncbi.nlm.nih.gov/11883098/) Glasspool-Malone J, Malone RW.  In Gene Therapy Methods: Methods Enzymol. 2002;346:72-91 -  [Cutaneous transfection and immune responses to intradermal nucleic acid vaccination are significantly enhanced by in vivo electropermeabilization.](https://pubmed.ncbi.nlm.nih.gov/11237682/) Drabick JJ, Glasspool-Malone J, …, Malone RW. Mol Ther. 2001;3(2):249-55. Cited in 192 articles. -  [Theory and in vivo application of electroporative gene delivery.](https://pubmed.ncbi.nlm.nih.gov/11237682/) Somiari S, Glasspool-Malone J, … Malone RW.  Mol Ther. 2000;2(3):178-87. Cited in 345 articles. -  [Efficient nonviral cutaneous transfection.](https://www.sciencedirect.com/science/article/pii/S1525001600901072) Glasspool-Malone J, …, Malone RW. Mol Ther. 2000;2(2):140-6. Cited in 138 articles. -  [Developing dendritic cell polynucleotide vaccination for prostate cancer immunotherapy.](https://pubmed.ncbi.nlm.nih.gov/10486925/) Berlyn KA, …,  Malone RW J Biotechnol. 1999;73(2-3):155-79 -  [Models of Cationic Liposome Mediated Transfection.  Gene Therapy and Molecular Biology. Ahearn A, Malone RW. Vol 4. Gene Therapy and Molecular Biology 1999;4](http://gtmb.org/volumes/Vol4/_14FC%20MALONE%20159-170.pdf) -  [Cationic lipid-mediated gene delivery to murine lung: correlation of lipid hydration with in vivo transfection activity. Bennett MJ, …, Malone RW, Nantz MH. J Med Chem. 1997;40(25):4069-78](https://pubs.acs.org/doi/10.1021/jm970155q) -  [Considerations for the design of improved cationic amphiphile-based transfection reagents. Bennett MJ, …, Malone RW. Journal of Liposome Research  1996;6(3):545-65](https://www.tandfonline.com/doi/abs/10.3109/08982109609031136) -  [Structural and functional analysis of cationic transfection lipids: the hydrophobic domain. Balasubramaniam RP, …, Malone RW. Gene Ther. 1996;3(2):163-72. cited in 172 articles.](https://pubmed.ncbi.nlm.nih.gov/8867864/) -  [A flexible approach to synthetic lipid ammonium salts for polynucleotide transfection. MJ Bennett, RW Malone, MH Nantz. Tetrahedron letters 36 (13), 2207-2210](https://www.sciencedirect.com/science/article/abs/pii/004040399500276I) [For the written history of the early events, by Dr. Jill Glasspool Malone](https://static1.squarespace.com/static/617d909092cd2314e37ebe67/t/617de3cd04bffe53342539cb/1635640269719/Jill%27s+letter+about+RNA+vaccination+generic+v5+June2021.pdf)